|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Selling, general, and administrative expenses | |||||
| Amortization of intangibles and other assets | |||||
| Goodwill and Intangible Asset Impairment | |||||
| Asset Impairment Charges | |||||
| Restructuring and other charges | |||||
| Operating income | |||||
| Interest expense | |||||
| Investment income | |||||
| Equity method loss, net | |||||
| Other, net | |||||
| Earnings from continuing operations before income taxes | |||||
| Provision for income taxes | |||||
| Earnings from continuing operations | |||||
| Earnings from discontinued operations, net of tax | |||||
| Net earnings | |||||
| Less: Net earnings attributable to the noncontrolling interest | |||||
| Net earnings attributable to Labcorp Holdings Inc. | |||||
| Basic earnings per share from continuing operations | |||||
| Basic earnings per share from discontinued operations | |||||
| Basic earnings per share | |||||
| Diluted earnings per share from continuing operations | |||||
| Diluted earnings per share from discontinued operations | |||||
| Diluted earnings per share | |||||
Loading...
